Clinical trial
Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for…
NCT00186797 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186797 |
|---|---|
| Title | Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia |
| Acronym | AACD34 |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Drug, Procedure |
| Interventions | Allogeneic stem cell transplant, Fludarabine, Cyclophosphamide |
| Enrollment | 28 |
| Start date | Dec 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 9, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: